Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1 CNS 1

Conditions

Melanoma 1 Brain Neoplasms 1

Interventions

pembrolizumab 514 Specimen Handling 384 Carboplatin 372 Magnetic Resonance Spectroscopy 337 Cisplatin 327 Nivolumab 301 Cyclophosphamide 297 Radiotherapy 255 Paclitaxel 255 Biopsy 237 Gemcitabine 229 Bevacizumab 212 Dexamethasone 168 durvalumab 162 Oxaliplatin 159 Capecitabine 154 Rituximab 153 Fluorouracil 148 venetoclax 143 atezolizumab 142 Drug Therapy 140 Docetaxel 140 Etoposide 139 Doxorubicin 132 Ipilimumab 124 Lenalidomide 119 Radiosurgery 118 Prednisone 116 Leucovorin 112 fludarabine 109

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Salvage Therapy × 1 year × Clear all

NCT03340129 2026-02-02

ABC-X

Melanoma Institute Australia

Phase 2 Recruiting

CNSDermatologic

Brain Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡